欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
FR/H/0554/001
药品名称
BABIVEN NN1
活性成分
calcium gluconate 4.2 g/l
glucose monohydrate 110.0 g/l
magnesium lactate 0.48 g/l
threonine 0.84 g/l
zinc acetate, basic 6.8 mg/l
valine 0.84 g/l
tyrosine 0.12 g/l
tryptophan 0.33 g/l
sodium fluoride 0.18 mg/l
serine 0.88 g/l
proline 1.28 g/l
potassium iodide 0.01 mg/l
phenylalanine 0.64 g/l
methionine 0.28 g/l
manganese(II)chloride 0.02 mg/l
lysine monohydrate 1.44 g/l
leucine 1.6 g/l
isoleucine 0.72 g/l
histidine 0.48 g/l
glycine 0.48 g/l
glutamic acid 1.64 g/l
copper sulfate 0.92 mg/l
chromium(III)chloride hexahydrate 0.01 mg/l
aspartic acid 0.96 g/l
arginine 0.96 g/l
alanine 1.44 g/l
acetylcysteine 0.32 g/l
剂型
Solution for infusion
上市许可持有人
Fresenius Kabi France
参考成员国 - 产品名称
France (FR)
互认成员国 - 产品名称
Belgium (BE)
Kidiamix
Netherlands (NL)
Austria (AT)
Pediaven Glucose 10% kaliumfrei Infusionslösung
Portugal (PT)
Italy (IT)
Poland (PL)
Latvia (LV)
Pediaven Start-Up Potassium Free šķīdums infūzijām
Lithuania (LT)
Pediaven NN1 infuzinis tirpalas
Estonia (EE)
PEDIAVEN NN1
许可日期
2014/05/05
最近更新日期
2020/03/09
药物ATC编码
B05BA10 combinations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Initial Application
TypeLevel3:
Bibliographic Art 10 a Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase